Mechanism-Based Therapeutics for Autosomal Dominant Polycystic Kidney Disease: Recent Progress and Future Prospects

Publisher： Karger

E-ISSN： 1660-2110|120|1|c25-c35

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.120, Iss.1, 2011-12, pp. : c25-c35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Practical Genetics for Autosomal Dominant Polycystic Kidney Disease

By  

Nephron Clin Pract, Vol. 118, Iss. 1, 2010-11 ,pp. : c19-c30

Karger

Access to resources Recommend Favorite

Retroperitoneoscopic Nephrectomy for Autosomal Dominant Polycystic Kidney Disease: Initial Experience

By  

Urologia Internationalis, Vol. 79, Iss. 2, 2007-09 ,pp. : 137-141

Karger

Access to resources Recommend Favorite

Recurrent Pancreatitis in a Patient with Autosomal-Dominant Polycystic Kidney Disease

By  

Pancreatology, Vol. 6, Iss. 1-2, 2006-04 ,pp. : 160-162

Karger

Access to resources Recommend Favorite

Cutaneous Microcirculation Is Impaired in Early Autosomal Dominant Polycystic Kidney Disease

By  

Nephron Clin Pract, Vol. 113, Iss. 2, 2009-07 ,pp. : c71-c75

Karger

Access to resources Recommend Favorite

Carbohydrate antigen 19–9 is significantly elevated in autosomal dominant polycystic kidney disease

By  

NEPHROLOGY, Vol. 23, Iss. 3, 2018-03 ,pp. : 210-216

John Wiley & Sons Inc

Access to resources Recommend Favorite